SHINE Medical Technologies is dedicated to being the world leader in safe, clean, affordable production of medical tracers and cancer treatment elements. At SHINE, our highest priority is delivering a highly reliable, high-quality supply of the medical ingredients required by nearly 100,000 patients each day which are the backbone of over thirty medical procedures primarily used to detect and treat heart disease and cancer. By working around the clock, our goal is to ensure that medical tracers are there when patients need them most.
SHINE announces first sales of its non-carrier-added lutetium-177
SHINE closes $80-million Series C financing supported by Fidelity Management and Research Company LLC
In addition to creating a company that may soon supply two-thirds of the global demand for radioisotopes used in medical imaging, Wisconsin’s Greg Piefer is moving towards plans to create machinery that will produce clean energy and solve nuclear waste issues. At the...
SHINE and IOCB Prague deliver patient dose quantities of lutetium-177 to GE Healthcare, advance therapeutic isotope toward commercialization
A crucial short-lived isotope is in short supply
One fear raised by those who oppose Britain’s leaving the European Union without a deal is that the import of radioactive isotopes for medicine would be at risk. These short-lived substances might, people wo
Medical isotopes maker Shine Medical Technologies last week created a division to make therapeutic products, saying it plans to first focus on a cancer treatment. The Janesville, Wis.-based company said its Shine Therapeutics business will begin with the development...
Record breaking fusion reaction could transform medical isotope production 04 Oct 2019 Tami Freeman The Phoenix neutron generator is installed at SHINE Medical Technologies' isotope production campus in Wisconsin. (Courtesy: Phoenix/SHINE) Nuclear technology...
Phoenix and SHINE Achieve New World Record for Strongest Nuclear Fusion Reaction in a Steady-State System
Leading nuclear technology companies collaborating to help turn nuclear weapons into medicine and help a billion patients
Breakthrough has potential to transform medical isotope production, solve a global health care shortage, provide a stepping stone to cleaner, safer, more abundant energy
JANESVILLE, Wis., Sept. 12, 2019 –SHINE Medical Technologies LLC today announced that its founder and CEO Greg Piefer has received the University of Wisconsin-Madison Department of Physics’ 2019 Distinguished Alumni Award.
JANESVILLE, Wis., Aug. 26, 2019 – SHINE Medical Technologies, LLC today announced the appointment of Paul D. Ryan to the company’s board of directors.